PLAT and stroke disorder: Despite the increasing incidence of ischemic stroke in the general population [40], the only FDA-approved and effective therapeutic approach post-stroke is to rescue the potentially recoverable infarct area through reperfusion using tissue plasminogen activator (tPA) [41].